Grinzaid KA - Search Results

1

Implementation of a Carrier Screening Program in a High-Risk Undergraduate Student Population Using Digital Marketing, Online Education, and Telehealth.

Hardy MW, Kener HJ, Grinzaid KA. Hardy MW, et al. Among authors: grinzaid ka. Public Health Genomics. 2018;21(1-2):67-76. doi: 10.1159/000493971. Epub 2018 Nov 8. Public Health Genomics. 2018. PMID: 30408784

2

Evaluating the experiences of individuals with personal health risks identified through expanded carrier screening.

Brown EM, Grinzaid KA, Ali N, Mehta N, Hardy MW. Brown EM, et al. Among authors: grinzaid ka. J Genet Couns. 2022 Jun;31(3):598-607. doi: 10.1002/jgc4.1527. Epub 2021 Oct 25. J Genet Couns. 2022. PMID: 34695254

3

Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study.

Rose E, Hardy MW, Gates R, Stanislaw C, Meisel J, Grinzaid KA. Rose E, et al. Among authors: grinzaid ka. Public Health Genomics. 2022 Aug 9:1-14. doi: 10.1159/000525658. Online ahead of print. Public Health Genomics. 2022. PMID: 35944511 Free article.

4

Patients' reactions and follow-up testing decisions related to Tay-Sachs (HEXA) variants of uncertain significance results.

Yip T, Grinzaid KA, Bellcross C, Moore RH, Page PZ, Hardy MW. Yip T, et al. Among authors: grinzaid ka. J Genet Couns. 2019 Aug;28(4):738-749. doi: 10.1002/jgc4.1108. Epub 2019 Mar 7. J Genet Couns. 2019. PMID: 30843643

5

Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.

Cecchi AC, Vengoechea ES, Kaseniit KE, Hardy MW, Kiger LA, Mehta N, Haque IS, Moyer K, Page PZ, Muzzey D, Grinzaid KA. Cecchi AC, et al. Among authors: grinzaid ka. Mol Genet Genomic Med. 2019 Aug;7(8):e836. doi: 10.1002/mgg3.836. Epub 2019 Jul 10. Mol Genet Genomic Med. 2019. PMID: 31293106 Free PMC article.

6

Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Hardy MW, Peshkin BN, Rose E, Ladd MK, Binion S, Tynan M, McBride CM, Grinzaid KA, Schwartz MD. Hardy MW, et al. Among authors: grinzaid ka. J Community Genet. 2022 Jun;13(3):281-292. doi: 10.1007/s12687-022-00590-3. Epub 2022 Apr 29. J Community Genet. 2022. PMID: 35486291 Free PMC article.

7

Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.

Grinzaid KA, Page PZ, Denton JJ, Ginsberg J. Grinzaid KA, et al. J Genet Couns. 2015 Jun;24(3):381-7. doi: 10.1007/s10897-014-9800-x. Epub 2014 Dec 12. J Genet Couns. 2015. PMID: 25502003

8

Evaluation of two-year Jewish genetic disease screening program in Atlanta: insight into community genetic screening approaches.

Shao Y, Liu S, Grinzaid K. Shao Y, et al. J Community Genet. 2015 Apr;6(2):137-45. doi: 10.1007/s12687-014-0208-y. Epub 2015 Jan 7. J Community Genet. 2015. PMID: 25564014 Free PMC article.

9

Cessation of enzyme replacement therapy in Gaucher disease.

Grinzaid KA, Geller E, Hanna SL, Elsas LJ 2nd. Grinzaid KA, et al. Genet Med. 2002 Nov-Dec;4(6):427-33. doi: 10.1097/00125817-200211000-00005. Genet Med. 2002. PMID: 12509713

10

Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypes.

Zhao H, Bailey LA, Elsas LJ 2nd, Grinzaid KA, Grabowski GA. Zhao H, et al. Among authors: grinzaid ka. Am J Med Genet A. 2003 Jan 1;116A(1):52-6. doi: 10.1002/ajmg.a.10029. Am J Med Genet A. 2003. PMID: 12476451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters